{"id":351783,"date":"2025-08-26T06:26:39","date_gmt":"2025-08-26T06:26:39","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ionis-pharmaceuticals\/"},"modified":"2025-08-26T06:26:39","modified_gmt":"2025-08-26T06:26:39","slug":"how-to-buy-ionis-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/","title":{"rendered":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-351783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Ionis Pharmaceuticals, Inc. (IONS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m s\u00fcrecini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Ionis Pharmaceuticals, Inc. (IONS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m s\u00fcrecini \u00f6\u011frenin."},"intro":"\u0130leri d\u00fczey t\u0131bbi yenili\u011fe yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Ionis Pharmaceuticals, RNA tabanl\u0131 terapilerin gelece\u011fini temsil ediyor\u2014nadir hastal\u0131klar\u0131n tedavisinde devrim yaratan bir \u015firket. Son FDA onaylar\u0131 ve patlay\u0131c\u0131 gelir art\u0131\u015f\u0131 ile bu biyoteknoloji \u00f6nc\u00fcs\u00fc hem heyecan verici potansiyel hem de \u00f6nemli riskler sunuyor. IONS'un portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini ve nas\u0131l hareket edece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri d\u00fczey t\u0131bbi yenili\u011fe yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Ionis Pharmaceuticals, RNA tabanl\u0131 terapilerin gelece\u011fini temsil ediyor\u2014nadir hastal\u0131klar\u0131n tedavisinde devrim yaratan bir \u015firket. Son FDA onaylar\u0131 ve patlay\u0131c\u0131 gelir art\u0131\u015f\u0131 ile bu biyoteknoloji \u00f6nc\u00fcs\u00fc hem heyecan verici potansiyel hem de \u00f6nemli riskler sunuyor. IONS'un portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini ve nas\u0131l hareket edece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Stratejisi<\/h2> <p>26 A\u011fustos 2025 itibar\u0131yla Ionis Pharmaceuticals (IONS) <strong>42,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014giri\u015f yapmay\u0131 d\u00fc\u015f\u00fcnen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir d\u00f6neme\u00e7. Hisse senedi, genel piyasa volatilitesine ra\u011fmen ola\u011fan\u00fcst\u00fc bir diren\u00e7 g\u00f6sterdi, ancak sat\u0131n alma zamanlaman\u0131z\u0131 belirlemek i\u00e7in yakla\u015fan tetikleyicileri anlaman\u0131z gerekiyor.<\/p> <p><strong>Takviminize not edin: 5 Kas\u0131m 2025<\/strong>, IONS'un y\u00f6n\u00fcn\u00fc dramatik \u015fekilde de\u011fi\u015ftirebilecek bir sonraki kazan\u00e7 tarihidir. Tarihsel desenler, bu \u015firketin sadece kazan\u00e7 raporu vermekle kalmay\u0131p, ayn\u0131 zamanda piyasalarda sars\u0131c\u0131 hareketler yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 IONS Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>30 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131 A\u015ft\u0131<\/td><td>41,48 $<\/td><td><strong>%4,56 Art\u0131\u015f<\/strong> (ayn\u0131 g\u00fcn)<\/td><\/tr> <tr><td>30 Nisan 2025<\/td><td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>38,20 $<\/td><td>%3,1 Art\u0131\u015f (hafta)<\/td><\/tr> <tr><td>30 Ocak 2025<\/td><td>Y\u0131ll\u0131k Rapor<\/td><td>36,80 $<\/td><td>%5,8 Art\u0131\u015f (tahminleri a\u015ft\u0131)<\/td><\/tr> <tr><td>30 Ekim 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>35,40 $<\/td><td>%2,9 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>30 Temmuz 2024<\/td><td>Ortakl\u0131k Haberi<\/td><td>33,10 $<\/td><td>%7,2 Art\u0131\u015f (Ono Pharma anla\u015fmas\u0131)<\/td><\/tr> <tr><td>30 Nisan 2024<\/td><td>Klinik Deneme Sonu\u00e7lar\u0131<\/td><td>31,50 $<\/td><td>%12,4 Art\u0131\u015f (pozitif veri)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: IONS, beklentileri a\u015ft\u0131\u011f\u0131nda yat\u0131r\u0131mc\u0131lar\u0131n\u0131 s\u00fcrekli \u00f6d\u00fcllendiriyor; son alt\u0131 raporda kazan\u00e7 sonras\u0131 ortalama %5,3 art\u0131\u015f ya\u015fand\u0131. 30 Temmuz 2025'teki <strong>%58 gelir art\u0131\u015f\u0131<\/strong> sonras\u0131 patlama, bu hissenin olumlu haberlerle ne kadar dramatik hareket edebilece\u011fini g\u00f6steriyor.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3> <p>IONS hisseleri bu d\u00f6nemde etkileyici bir <strong>%19,6<\/strong> performans sergiledi:<\/p> <ul> <li><strong>Mart 2025<\/strong>: 35,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li> <li><strong>Nisan 2025<\/strong>: 38,60 $ (1. \u00e7eyrek kazan\u00e7 iyimserli\u011fi)<\/li> <li><strong>May\u0131s 2025<\/strong>: 40,10 $ (ortakl\u0131k s\u00f6ylentileri)<\/li> <li><strong>Haziran 2025<\/strong>: 39,80 $ (piyasa volatilitesi)<\/li> <li><strong>Temmuz 2025<\/strong>: 43,37 $ (kazan\u00e7 sonras\u0131 zirve)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 42,17 $ (g\u00fcncel konsolidasyon)<\/li> <\/ul> <p><strong>G\u00fc\u00e7 neden?<\/strong> \u015eirketin RNA tabanl\u0131 terapi platformu, birden fazla d\u00fczenleyici d\u00f6n\u00fcm noktas\u0131yla onay ald\u0131 ve Ono Pharmaceutical'dan al\u0131nan <strong>280 milyon $ \u00f6n \u00f6deme<\/strong> nakit pozisyonlar\u0131n\u0131 2 milyar $'a y\u00fckseltti.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 Y\u0131l Sonu<\/strong>: 48-52 $ (pipeline ilerlemesi devam ediyor) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026 Hedefi<\/strong>: 55-65 $ (Avrupa geni\u015flemesi ve yeni lansmanlar)<br\/> <strong>2028 Projeksiyonu<\/strong>: 85-110 $ (birden fazla blockbuster ila\u00e7 onay\u0131)<br\/> <strong>2030 Vizyonu<\/strong>: 120-150 $ (k\u00fcresel RNA terapi hakimiyeti)<\/p> <p><strong>Karar<\/strong>: IONS, sab\u0131r ve risk tolerans\u0131 olan yat\u0131r\u0131mc\u0131lar i\u00e7in y\u00fcksek riskli, y\u00fcksek getirili bir f\u0131rsat sunuyor. Temmuz zirvelerinden gelen mevcut d\u00fc\u015f\u00fc\u015f, Kas\u0131m kazan\u00e7lar\u0131ndan \u00f6nce cazip bir giri\u015f noktas\u0131 sa\u011fl\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong> - Son ba\u015far\u0131lar\u0131na ra\u011fmen deneysel ila\u00e7lar\u0131n %90'\u0131 ba\u015far\u0131s\u0131z oluyor. Bir olumsuz deneme, piyasa de\u011ferinden milyarlarca dolar silebilir.<\/li> <li><strong>D\u00fczenleyici engeller<\/strong> - FDA onay s\u00fcreci, \u00f6zellikle yeni RNA terapileri i\u00e7in \u00f6ng\u00f6r\u00fclemezli\u011fini koruyor.<\/li> <li><strong>Mali s\u00fcrd\u00fcr\u00fclebilirlik<\/strong> - <strong>-1,84 $ negatif EPS<\/strong> ve y\u0131ll\u0131k 368 milyon $ negatif nakit ak\u0131\u015f\u0131 ile karl\u0131l\u0131k tamamen gelecekteki ila\u00e7 ba\u015far\u0131lar\u0131na ba\u011fl\u0131.<\/li> <li><strong>Fiyat bask\u0131lar\u0131<\/strong> - ABD ve AB pazarlar\u0131nda y\u00fcksek ila\u00e7 fiyatlar\u0131na kar\u015f\u0131 artan diren\u00e7, gelir potansiyelini s\u0131n\u0131rlayabilir.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi<\/strong> - 2. \u00e7eyrek 2025 geliri <strong>452 milyon $ ile tahminleri %58 a\u015ft\u0131<\/strong>, ticari uygulaman\u0131n i\u015fe yarad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/li> <li><strong>Pipeline ivmesi<\/strong> - Donidalorsen, olezarsen ve zilganersen dahil olmak \u00fczere birden fazla ge\u00e7 a\u015fama aday, <strong>4-5 milyar $ pazar f\u0131rsat\u0131<\/strong> sunuyor.<\/li> <li><strong>Stratejik ortakl\u0131klar<\/strong> - <strong>280 milyon $ Ono Pharmaceutical anla\u015fmas\u0131<\/strong> teknolojilerini do\u011fruluyor ve seyrelmeyen finansman sa\u011fl\u0131yor.<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong> - RNA terap\u00f6tikleri, biyofarma sekt\u00f6r\u00fcnde en h\u0131zl\u0131 b\u00fcy\u00fcyen segment olup, 2030'a kadar y\u0131ll\u0131k %22 b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcl\u00fcyor.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 IONS'a ay\u0131rmay\u0131n. Biyoteknoloji volatilitesi yeni ba\u015flayanlar i\u00e7in zorlu olabilir.<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> - Tek seferlik b\u00fcy\u00fck al\u0131m yerine, haftal\u0131k 100-200 $ al\u0131m yaparak giri\u015f noktalar\u0131n\u0131 yumu\u015fatmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li> <li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong> - Hissenin volatilitesi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda sermayenizi %15-20 stop-loss ile koruyun.<\/li> <li><strong>5 Kas\u0131m'\u0131 takip edin<\/strong> - Bir sonraki kazan\u00e7 raporu, ya harika bir giri\u015f f\u0131rsat\u0131 ya da y\u00fckseli\u015f trendinin teyidi olabilir.<\/li> <\/ol> <p>Esprili bir yorum: \"IONS ile i\u015flem yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014i\u015fler yolunda gitti\u011finde inan\u0131lmaz heyecan verici, ama laboratuvarda beklenmedik patlamalara haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"IONS\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri, volatilite s\u0131ras\u0131nda fazla \u00f6deme yapman\u0131z\u0131 \u00f6nler<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu izleyin<\/td><td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, IONS gibi hisselerde i\u015flem yapmak i\u00e7in birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - Daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> - Tek belge KYC ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Kripto paralar ve e-c\u00fczdanlar dahil 100'den fazla y\u00f6ntemle karlar\u0131n\u0131za eri\u015fin<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - Biyoteknoloji yat\u0131r\u0131mlar\u0131nda yeni olanlar i\u00e7in sezgisel aray\u00fcz<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Ionis: RNA Terapi \u00d6nc\u00fcs\u00fc<\/h2> <p>Ionis Pharmaceuticals, antisense oligon\u00fckleotid teknolojisiyle t\u0131bbi yenili\u011fin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirket, RNA terap\u00f6tik alan\u0131nda birden fazla onayl\u0131 ila\u00e7 ve nadir genetik hastal\u0131klardan muzdarip milyonlarca ki\u015fiyi tedavi edebilecek bir pipeline ile hakimiyet kuruyor.<\/p> <p><strong>2025 at\u0131l\u0131m\u0131<\/strong>: \u015eirketin genel merkezi art\u0131k her ba\u015far\u0131l\u0131 ila\u00e7 geli\u015ftirmeden al\u0131nan \u015fi\u015feleri sergileyen bir \"\u0130yile\u015ftirmeler Duvar\u0131\"na sahip\u2014her hisse fiyat hareketinin hastalar\u0131n hayatlar\u0131n\u0131 etkileyen ger\u00e7ek t\u0131bbi ilerlemeyi temsil etti\u011finin g\u00fc\u00e7l\u00fc bir hat\u0131rlat\u0131c\u0131s\u0131.<\/p> <h3>\u0130lgin\u00e7 Bir Ger\u00e7ek:<\/h3> <p>Ionis bilim insanlar\u0131, RNA teknolojilerinin ba\u015flang\u0131\u00e7ta hedeflemedikleri durumlar\u0131 tedavi etmek i\u00e7in uyarlanabilece\u011fini ke\u015ffettiler\u2014bu da mevcut 5,28 milyar $ de\u011ferlemelerini g\u00f6lgede b\u0131rakabilecek potansiyel pazar f\u0131rsatlar\u0131n\u0131n kap\u0131s\u0131n\u0131 a\u00e7\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Giri\u015f Stratejisi<\/h2>\n<p>26 A\u011fustos 2025 itibar\u0131yla Ionis Pharmaceuticals (IONS) <strong>42,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014giri\u015f yapmay\u0131 d\u00fc\u015f\u00fcnen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir d\u00f6neme\u00e7. Hisse senedi, genel piyasa volatilitesine ra\u011fmen ola\u011fan\u00fcst\u00fc bir diren\u00e7 g\u00f6sterdi, ancak sat\u0131n alma zamanlaman\u0131z\u0131 belirlemek i\u00e7in yakla\u015fan tetikleyicileri anlaman\u0131z gerekiyor.<\/p>\n<p><strong>Takviminize not edin: 5 Kas\u0131m 2025<\/strong>, IONS&#8217;un y\u00f6n\u00fcn\u00fc dramatik \u015fekilde de\u011fi\u015ftirebilecek bir sonraki kazan\u00e7 tarihidir. Tarihsel desenler, bu \u015firketin sadece kazan\u00e7 raporu vermekle kalmay\u0131p, ayn\u0131 zamanda piyasalarda sars\u0131c\u0131 hareketler yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 IONS Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>30 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131 A\u015ft\u0131<\/td>\n<td>41,48 $<\/td>\n<td><strong>%4,56 Art\u0131\u015f<\/strong> (ayn\u0131 g\u00fcn)<\/td>\n<\/tr>\n<tr>\n<td>30 Nisan 2025<\/td>\n<td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>38,20 $<\/td>\n<td>%3,1 Art\u0131\u015f (hafta)<\/td>\n<\/tr>\n<tr>\n<td>30 Ocak 2025<\/td>\n<td>Y\u0131ll\u0131k Rapor<\/td>\n<td>36,80 $<\/td>\n<td>%5,8 Art\u0131\u015f (tahminleri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>30 Ekim 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>35,40 $<\/td>\n<td>%2,9 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>30 Temmuz 2024<\/td>\n<td>Ortakl\u0131k Haberi<\/td>\n<td>33,10 $<\/td>\n<td>%7,2 Art\u0131\u015f (Ono Pharma anla\u015fmas\u0131)<\/td>\n<\/tr>\n<tr>\n<td>30 Nisan 2024<\/td>\n<td>Klinik Deneme Sonu\u00e7lar\u0131<\/td>\n<td>31,50 $<\/td>\n<td>%12,4 Art\u0131\u015f (pozitif veri)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: IONS, beklentileri a\u015ft\u0131\u011f\u0131nda yat\u0131r\u0131mc\u0131lar\u0131n\u0131 s\u00fcrekli \u00f6d\u00fcllendiriyor; son alt\u0131 raporda kazan\u00e7 sonras\u0131 ortalama %5,3 art\u0131\u015f ya\u015fand\u0131. 30 Temmuz 2025&#8217;teki <strong>%58 gelir art\u0131\u015f\u0131<\/strong> sonras\u0131 patlama, bu hissenin olumlu haberlerle ne kadar dramatik hareket edebilece\u011fini g\u00f6steriyor.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3>\n<p>IONS hisseleri bu d\u00f6nemde etkileyici bir <strong>%19,6<\/strong> performans sergiledi:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: 35,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Nisan 2025<\/strong>: 38,60 $ (1. \u00e7eyrek kazan\u00e7 iyimserli\u011fi)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 40,10 $ (ortakl\u0131k s\u00f6ylentileri)<\/li>\n<li><strong>Haziran 2025<\/strong>: 39,80 $ (piyasa volatilitesi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 43,37 $ (kazan\u00e7 sonras\u0131 zirve)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 42,17 $ (g\u00fcncel konsolidasyon)<\/li>\n<\/ul>\n<p><strong>G\u00fc\u00e7 neden?<\/strong> \u015eirketin RNA tabanl\u0131 terapi platformu, birden fazla d\u00fczenleyici d\u00f6n\u00fcm noktas\u0131yla onay ald\u0131 ve Ono Pharmaceutical&#8217;dan al\u0131nan <strong>280 milyon $ \u00f6n \u00f6deme<\/strong> nakit pozisyonlar\u0131n\u0131 2 milyar $&#8217;a y\u00fckseltti.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 48-52 $ (pipeline ilerlemesi devam ediyor) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026 Hedefi<\/strong>: 55-65 $ (Avrupa geni\u015flemesi ve yeni lansmanlar)<br \/> <strong>2028 Projeksiyonu<\/strong>: 85-110 $ (birden fazla blockbuster ila\u00e7 onay\u0131)<br \/> <strong>2030 Vizyonu<\/strong>: 120-150 $ (k\u00fcresel RNA terapi hakimiyeti)<\/p>\n<p><strong>Karar<\/strong>: IONS, sab\u0131r ve risk tolerans\u0131 olan yat\u0131r\u0131mc\u0131lar i\u00e7in y\u00fcksek riskli, y\u00fcksek getirili bir f\u0131rsat sunuyor. Temmuz zirvelerinden gelen mevcut d\u00fc\u015f\u00fc\u015f, Kas\u0131m kazan\u00e7lar\u0131ndan \u00f6nce cazip bir giri\u015f noktas\u0131 sa\u011fl\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong> &#8211; Son ba\u015far\u0131lar\u0131na ra\u011fmen deneysel ila\u00e7lar\u0131n %90&#8217;\u0131 ba\u015far\u0131s\u0131z oluyor. Bir olumsuz deneme, piyasa de\u011ferinden milyarlarca dolar silebilir.<\/li>\n<li><strong>D\u00fczenleyici engeller<\/strong> &#8211; FDA onay s\u00fcreci, \u00f6zellikle yeni RNA terapileri i\u00e7in \u00f6ng\u00f6r\u00fclemezli\u011fini koruyor.<\/li>\n<li><strong>Mali s\u00fcrd\u00fcr\u00fclebilirlik<\/strong> &#8211; <strong>-1,84 $ negatif EPS<\/strong> ve y\u0131ll\u0131k 368 milyon $ negatif nakit ak\u0131\u015f\u0131 ile karl\u0131l\u0131k tamamen gelecekteki ila\u00e7 ba\u015far\u0131lar\u0131na ba\u011fl\u0131.<\/li>\n<li><strong>Fiyat bask\u0131lar\u0131<\/strong> &#8211; ABD ve AB pazarlar\u0131nda y\u00fcksek ila\u00e7 fiyatlar\u0131na kar\u015f\u0131 artan diren\u00e7, gelir potansiyelini s\u0131n\u0131rlayabilir.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi<\/strong> &#8211; 2. \u00e7eyrek 2025 geliri <strong>452 milyon $ ile tahminleri %58 a\u015ft\u0131<\/strong>, ticari uygulaman\u0131n i\u015fe yarad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/li>\n<li><strong>Pipeline ivmesi<\/strong> &#8211; Donidalorsen, olezarsen ve zilganersen dahil olmak \u00fczere birden fazla ge\u00e7 a\u015fama aday, <strong>4-5 milyar $ pazar f\u0131rsat\u0131<\/strong> sunuyor.<\/li>\n<li><strong>Stratejik ortakl\u0131klar<\/strong> &#8211; <strong>280 milyon $ Ono Pharmaceutical anla\u015fmas\u0131<\/strong> teknolojilerini do\u011fruluyor ve seyrelmeyen finansman sa\u011fl\u0131yor.<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong> &#8211; RNA terap\u00f6tikleri, biyofarma sekt\u00f6r\u00fcnde en h\u0131zl\u0131 b\u00fcy\u00fcyen segment olup, 2030&#8217;a kadar y\u0131ll\u0131k %22 b\u00fcy\u00fcme \u00f6ng\u00f6r\u00fcl\u00fcyor.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 IONS&#8217;a ay\u0131rmay\u0131n. Biyoteknoloji volatilitesi yeni ba\u015flayanlar i\u00e7in zorlu olabilir.<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> &#8211; Tek seferlik b\u00fcy\u00fck al\u0131m yerine, haftal\u0131k 100-200 $ al\u0131m yaparak giri\u015f noktalar\u0131n\u0131 yumu\u015fatmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li>\n<li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong> &#8211; Hissenin volatilitesi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda sermayenizi %15-20 stop-loss ile koruyun.<\/li>\n<li><strong>5 Kas\u0131m&#8217;\u0131 takip edin<\/strong> &#8211; Bir sonraki kazan\u00e7 raporu, ya harika bir giri\u015f f\u0131rsat\u0131 ya da y\u00fckseli\u015f trendinin teyidi olabilir.<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;IONS ile i\u015flem yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014i\u015fler yolunda gitti\u011finde inan\u0131lmaz heyecan verici, ama laboratuvarda beklenmedik patlamalara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;IONS&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri, volatilite s\u0131ras\u0131nda fazla \u00f6deme yapman\u0131z\u0131 \u00f6nler<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, IONS gibi hisselerde i\u015flem yapmak i\u00e7in birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; Daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Tek belge KYC ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kripto paralar ve e-c\u00fczdanlar dahil 100&#8217;den fazla y\u00f6ntemle karlar\u0131n\u0131za eri\u015fin<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; Biyoteknoloji yat\u0131r\u0131mlar\u0131nda yeni olanlar i\u00e7in sezgisel aray\u00fcz<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Ionis: RNA Terapi \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Ionis Pharmaceuticals, antisense oligon\u00fckleotid teknolojisiyle t\u0131bbi yenili\u011fin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirket, RNA terap\u00f6tik alan\u0131nda birden fazla onayl\u0131 ila\u00e7 ve nadir genetik hastal\u0131klardan muzdarip milyonlarca ki\u015fiyi tedavi edebilecek bir pipeline ile hakimiyet kuruyor.<\/p>\n<p><strong>2025 at\u0131l\u0131m\u0131<\/strong>: \u015eirketin genel merkezi art\u0131k her ba\u015far\u0131l\u0131 ila\u00e7 geli\u015ftirmeden al\u0131nan \u015fi\u015feleri sergileyen bir &#8220;\u0130yile\u015ftirmeler Duvar\u0131&#8221;na sahip\u2014her hisse fiyat hareketinin hastalar\u0131n hayatlar\u0131n\u0131 etkileyen ger\u00e7ek t\u0131bbi ilerlemeyi temsil etti\u011finin g\u00fc\u00e7l\u00fc bir hat\u0131rlat\u0131c\u0131s\u0131.<\/p>\n<h3>\u0130lgin\u00e7 Bir Ger\u00e7ek:<\/h3>\n<p>Ionis bilim insanlar\u0131, RNA teknolojilerinin ba\u015flang\u0131\u00e7ta hedeflemedikleri durumlar\u0131 tedavi etmek i\u00e7in uyarlanabilece\u011fini ke\u015ffettiler\u2014bu da mevcut 5,28 milyar $ de\u011ferlemelerini g\u00f6lgede b\u0131rakabilecek potansiyel pazar f\u0131rsatlar\u0131n\u0131n kap\u0131s\u0131n\u0131 a\u00e7\u0131yor.<\/p>\n"},"faq":[{"question":"Ionis Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"IONS\" sembol\u00fcn\u00fc aray\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, i\u015flemi onaylay\u0131n ve pozisyonunuzu izleyin."},{"question":"IONS hisseleri i\u00e7in riskler nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici engeller, mali s\u00fcrd\u00fcr\u00fclebilirlik sorunlar\u0131 ve fiyat bask\u0131lar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"2025 i\u00e7in IONS hisse fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda 48-52 $ aral\u0131\u011f\u0131nda beklenmekte olup, g\u00fc\u00e7l\u00fc al\u0131m \u00f6nerilmektedir."},{"question":"Yeni ba\u015flayanlar i\u00e7in yat\u0131r\u0131m stratejisi nedir?","answer":"Portf\u00f6y\u00fcn %3-5'i ile k\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, s\u0131k\u0131 stop-loss kullan\u0131n ve \u00f6nemli kazan\u00e7 tarihlerini takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ve kullan\u0131c\u0131 dostu platform sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Ionis Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"IONS\" sembol\u00fcn\u00fc aray\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, i\u015flemi onaylay\u0131n ve pozisyonunuzu izleyin."},{"question":"IONS hisseleri i\u00e7in riskler nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici engeller, mali s\u00fcrd\u00fcr\u00fclebilirlik sorunlar\u0131 ve fiyat bask\u0131lar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"2025 i\u00e7in IONS hisse fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda 48-52 $ aral\u0131\u011f\u0131nda beklenmekte olup, g\u00fc\u00e7l\u00fc al\u0131m \u00f6nerilmektedir."},{"question":"Yeni ba\u015flayanlar i\u00e7in yat\u0131r\u0131m stratejisi nedir?","answer":"Portf\u00f6y\u00fcn %3-5'i ile k\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, s\u0131k\u0131 stop-loss kullan\u0131n ve \u00f6nemli kazan\u00e7 tarihlerini takip edin."},{"question":"Pocket Option neden yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ve kullan\u0131c\u0131 dostu platform sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T06:26:39+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-26T06:26:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\",\"name\":\"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-26T06:26:39+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-26T06:26:39+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-26T06:26:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/","name":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-26T06:26:39+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Ionis Pharmaceuticals, Inc. (IONS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ionis Pharmaceuticals, Inc. (IONS) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":351780,"slug":"how-to-buy-ionis-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ionis Pharmaceuticals, Inc. (IONS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ionis Pharmaceuticals, Inc. (IONS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":351778,"slug":"how-to-buy-ionis-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Ionis Pharmaceuticals, Inc. (IONS) - Investimento em a\u00e7\u00f5es da Ionis Pharmaceuticals, Inc. (IONS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ionis-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=351783"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351783\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=351783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=351783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=351783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}